Webinar | Nestlé and Arla are leading GLP-1 food innovation. Is your R&D keeping up?​ Register Now

CLAIRIgene

CLAIRIgene develops gene therapies for neurodegenerative diseases, focusing on precision medicine and epigenome editing.
2019
1-10
Durham, North Carolina, United States
  • Drug Discovery and Development
  • Personalized Medicine Technologies

Investment Funding

Revenue

$1M to $10M

People

Founders

Something missing or incorrect on this page? Help us enrich this information